Tempus
Tempus raises $410M Series G at $8.1B valuation
Quick Facts
Tempus: Series G Funding Round
Tempus has successfully raised $410M in Series G funding, reaching a valuation of $8.1B.
Company Overview
AI-enabled precision medicine platform
Funding Details
The Series G round was led by Baillie Gifford, with participation from Franklin Templeton, T. Rowe Price, New Enterprise Associates, Revolution, Google Ventures.
Company Information
- Headquarters: 600 West Chicago Avenue, Chicago, IL 60654
- Founded: 2015
- Employees: 2000+
- Category: HealthTech
Investment
Tempus plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Baillie Gifford: Verified investor in Series G
- Franklin Templeton: Verified investor in Series G
- T. Rowe Price: Verified investor in Series G
- New Enterprise Associates: Verified investor in Series G
- Revolution: Verified investor in Series G
- Google Ventures: Verified investor in Series G
Key Investors
About the Author
Related Company Reports
Zingage raises $12.5M Seed at $60M valuation
Zingage raises $12.5M in Seed at $60M valuation. AI platform for home healthcare coordination and patient engagement...
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
Duos raises $130M Growth Equity at $600M valuation
Duos raises $130M in Growth Equity at $600M valuation. Digital health platform for Medicare-focused patient care...